Investing.com - BioLineRx reported on Tuesday fourth quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.
BioLineRx announced earnings per share of $-0.25 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.2433 on revenue of $0.00.
BioLineRx shares are up 27.38% from the beginning of the year and are trading at $3.210 , down-from-52-week-high.They are outperforming the Nasdaq which is up 2.88% from the start of the year.
BioLineRx shares lost 6.69% in intra-day trade the report.
BioLineRx follows other major sector earnings this month
BioLineRx's report follows an earnings beat by Ping An Insurance Company of China on Wednesday, February 3, 2021, who reported EPS of $0.6308 on revenue of $26.15B, compared to forecasts EPS of $0.6304 on revenue of $24.08B.
SoftBank Group had beat expectations on Monday, February 8, 2021 with fourth quarter EPS of $2.97 on revenue of $14.41B, compared to forecast for EPS of $0.0374 on revenue of $12.93B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar